|
Targeted therapy of pancreatic cancer with in vivo radionuclide generator
|
1R21CA156088-01
|
$180,525
|
DADACHOVA, EKATERINA
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S1
|
$249,624
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S2
|
$249,624
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S3
|
$74,922
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
5P30CA013330-39
|
$3,725,702
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Community Clinical Oncology Program
|
5U10CA037422-24
|
$4,282,002
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RTOG Biospecimen Repository
|
2U24CA114734-06
|
$1,040,063
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group
|
3U10CA021661-35S1
|
$2,923,989
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RTOG Tissue Bank
|
3U24CA114734-05S2
|
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group
|
5U10CA021661-35
|
$10,630,221
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Targeted tumoricidal bacteria
|
5R44CA126023-03
|
$386,199
|
ZHAO, MING
|
ANTICANCER, INC.
|
|
Preclinical Development of iRGD for Pancreatic Cancer
|
1R43CA162766-01
|
$416,564
|
Slee, Deborah
|
ASPYRIAN THERAPEUTICS, INC.
|
|
PDX-1 is a Therapeutic Target for Pancreatic Cancer
|
5R01CA095731-09
|
$266,570
|
BRUNICARDI, FRANCIS
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-05S1
|
$75,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-05
|
$2,934,758
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Spatial and Temporal Regulation of Angiogenesis
|
5P01CA092644-08
|
$1,606,344
|
DVORAK, HAROLD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of Fibroblasts, Myeloid Cells and Matrix in PDAC
|
5U01CA151925-02
|
$648,725
|
KALLURI, RAGHU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The role of endothelial to mesenchymal transition (EndMT) in the tumor stroma
|
5K08CA129204-04
|
$135,270
|
ZEISBERG, ELISABETH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
SEROLOGICAL MARKERS OF PERIODONTAL DISEASE AND PANCREATIC CANCER RISK
|
5R21CA139193-02
|
$192,122
|
MICHAUD, DOMINIQUE
|
BROWN UNIVERSITY
|
|
The Revolving Door of Cancer Care For Older Americans
|
1R21CA161781-01
|
|
TENO, JOAN
|
BROWN UNIVERSITY
|
|
Fresno State-SBCC Partnership: Cancer Research & Training for Central PA (1 of 2)
|
5P20CA138025-02
|
$248,044
|
Junn, Ellen
|
CALIFORNIA STATE UNIVERSITY FRESNO
|
|
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis
|
5U01CA062502-18
|
$746,424
|
DOWLATI, AFSHIN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-22S1
|
$73,029
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-22S2
|
$50,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-22
|
$4,849,180
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Regulation of microRNA-16 by benzyl isothiocyanate in pancreatic cancer
|
5R21CA149785-02
|
$165,616
|
HALDAR, SUBRATA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Preclinical Studies on Polyunsaturated Fatty Acid-Taxoid Conjugate for IND Filing
|
5R44CA132396-03
|
$2,014,585
|
GUPTA, RAMESH
|
CHEM-MASTER INTERNATIONAL, INC
|
|
Targeting Neuropilin 2 with Semaphorin 3F during Pancreatic Carcinoma Progression
|
1R21CA155728-01A1
|
$188,863
|
BIELENBERG, DIANE
|
CHILDREN'S HOSPITAL BOSTON
|
|
Research and Mentoring on Energetic Factors and Cancer: Established Investigator
|
5K05CA136967-03
|
$139,569
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CXCL12/CXCR4 Signaling - A Novel Target for Pancreatic Intraepithelial Neoplasia
|
5K22CA134637-03
|
$191,700
|
KIM, JOSEPH
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
An integrative approach to cancer gene discovery in hepatocellular carcinoma
|
5R01CA124648-05
|
$435,619
|
POWERS, SCOTT
|
COLD SPRING HARBOR LABORATORY
|
|
CSHL CANCER CENTER SUPPORT GRANT
|
2P30CA045508-24
|
$4,306,037
|
STILLMAN, BRUCE
|
COLD SPRING HARBOR LABORATORY
|
|
Cancer Center Support Grant
|
5P30CA013696-38
|
$3,816,425
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-38S1
|
$74,998
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-38S2
|
$139,995
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer
|
1R01CA157980-01
|
$334,075
|
Olive, Kenneth
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Mouse Model for Human Pancreatic Ductal Adenocarcinoma
|
2R01CA109525-07A1
|
$250,358
|
SU, GLORIA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Myofibroblasts in Gastrointestinal Cancers
|
1U54CA163111-01
|
$505,000
|
WANG, TIMOTHY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Detection and Diagnosis of Pancreatic Carcinoma
|
5R01CA096924-06
|
$264,078
|
GOLD, DAVID
|
CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S5
|
$11,164,583
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S6
|
$75,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
|
2P01CA117969-06
|
$2,019,635
|
DEPINHO, RONALD
|
DANA-FARBER CANCER INSTITUTE
|
|
DF/HCC SPORE in Gastrointestinal Cancer
|
5P50CA127003-05
|
$2,185,000
|
FUCHS, CHARLES
|
DANA-FARBER CANCER INSTITUTE
|
|
Prospective Cohort Collaborative in Pancreatic Cancer Epidemiology & Pathogenesis
|
5R01CA124908-06
|
$746,660
|
FUCHS, CHARLES
|
DANA-FARBER CANCER INSTITUTE
|
|
Investigating the Role of Autophagy in Pancreatic Cancer Radiation Resistance
|
1R01CA157490-01
|
$346,239
|
Kimmelman, Alec
|
DANA-FARBER CANCER INSTITUTE
|
|
Technology for sensitive and reliable mutational profiling in pancreatic cancer
|
5R21CA138280-03
|
$256,242
|
Makrigiorgos, G.
|
DANA-FARBER CANCER INSTITUTE
|
|
The Genetics and Prevention of Gastrointestinal Cancers
|
5K24CA113433-07
|
$196,416
|
SYNGAL, SAPNA
|
DANA-FARBER CANCER INSTITUTE
|
|
Cohort Study of Biochemical and Genetic Risk Factors for Pancreatic Cancer
|
5K07CA140790-03
|
$177,777
|
Wolpin, Brian
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA023108-33
|
$3,125,750
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
New Triterpenoids for Chemoprevention and Therapy of Cancer
|
5R01CA078814-13
|
$340,825
|
Sporn, Michael
|
DARTMOUTH COLLEGE
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|